RecruitingPhase 4

Complex Treatment of a Chronic Anal Fissure

Russia340 participantsStarted 2019-09-01

Plain-language summary

This study is aimed at studying the efficacy and safety of treating chronic anal fissure with botulinum toxin versus lateral subcutaneous sphincterotomy.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with chronic anal fissure Exclusion Criteria: * Inflammatory diseases of the colon * Pectenosis * Previous surgical interventions on the anal canal * IV grade internal and external hemorrhoids * Rectal fistula * Severe somatic diseases at the decompensation stage * Pregnancy and lactation * Individual intolerance and hypersensitivity to botulinum toxin * Myasthenia gravis and myasthenia-like syndromes * Anal sphincter insufficiency

What they're measuring

Anal sphincter insufficiency

Timeframe: Up to 60 days

Trial details

NCT IDNCT03855046

SponsorState Scientific Centre of Coloproctology, Russian Federation

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-09-01

Contact for this trial

Evgeny E. Zharkov, MD

89039689739 drzharkov@mail.ru

View on ClinicalTrials.gov More Fissure in Ano trials